Nucleotide sequence analysis of the precore region in patients with spontaneous reactivation of chronic hepatitis B
- 13 Downloads
The role of HBV precore mutations in the spontaneous reactivation of chronic hepatitis B (CHB) is currently unknown. We studied 10 patients with CHB; five were HBeAg+ (group I) and five were anti-HBe+ (group II). All 10 had spontaneous reactivation of CHB as defined by the appearance of clinical symptoms along with an increase of serum ALT activity at least 5× above baseline values, in the absence of any other known causes of liver disease or CHB reactivation. The precore (87 nt) and proximal core (81 nt) regions were sequenced after PCR amplification. From each patient three serum samples were studied: one 3–12 months before, one during, and one six months after reactivation. Prior to reactivation, none of the group I patients harbored an HBV strain having a mutation that prevented HBeAg synthesis; however, 2/5 developed such a mutation during reactivation (G to A transition at nt 1896). Among the group II patients, three harbored an HBeAg defective mutant both before and during reactivation; after six months, two of these three patients were HBV DNA negative in serum by PCR. Several other sequence polymorphisms, some of which changed the predicted amino acid sequence, were either present initially or developed during reactivation. In conclusion, in this small group of CHB patients who were HBeAg+ spontaneous reactivation was accompanied in some cases by a shift to an HBeAg defective mutant, while in patients who were anti-HBe+, such mutations were frequently present prior to reactivation. In patients already harboring precore defective mutants, spontaneous reactivation may precede an attenuation of viral replication.
Key wordschronic hepatitis B precore region mutation nucleotide sequence
Unable to display preview. Download preview PDF.
- 3.Vento S, Di Perri G, Luzzati R, Cruciani M, Garofano T, Mengoli C, Concia E, Bassett D: Clinical reactivation of hepatitis B in anti-HBs positive patients with AIDS. Lancet 1:332–333, 1989Google Scholar
- 4.Tassopoulos NC, Papaevangelou GJ, Roumeliotou-Karayannis A: Reactivation of chronic hepatitis B as acute viral hepatitis. Ann Intern Med 103:481, 1985Google Scholar
- 17.Carman W, Thomas H, Domingo E: Viral genetic variation: Hepatitis B virus as a clinical example. Lancet 1:349–353, 1993Google Scholar
- 18.Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M: Hepatitis B viruses in precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64:1298–1303, 1990PubMedGoogle Scholar
- 23.Thomas HC, Montano L, Goodall A, De Koning R, Oladapo J, Wiedman KH: Immunological mechanisms in chronic B virus infection. Hepatology 2:116S-121S, 1982Google Scholar